Tirzepatide
A dual GIP/GLP-1 receptor agonist developed by Eli Lilly, described in clinical literature for type 2 diabetes and demonstrating body-weight changes of up to 22.5% in clinical trials. All presented information is based on scientific publications which can be found at the end of product description below.
Batch-level quality proof
Every research peptide is supplied as a sealed, clearly labelled vial. Batch-level CoA information and purity testing records are available online where applicable, not shipped as research paperwork in the parcel.
Clear label, lot traceability, protective packaging.
No COA report currently listed for this product/batch.
Not for human or veterinary use, no protocol or dosing advice.
Tirzepatide research authority cluster
Use these pages to connect Tirzepatide product data, GIP/GLP-1 receptor research context, quality testing standards, and online CoA information where applicable.
Product specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
Tirzepatide is a 39-amino-acid dual agonist of GIP and GLP-1 receptors. Marketed as Mounjaro (diabetes) and Zepbound (obesity), it is the first approved dual incretin receptor agonist. Research Highlights 1. Type 2 Diabetes — SURPASS trials showed HbA1c reductions of ~2.4% at 15mg, with substantial target achievement below 5.7%.
2. Weight Management — SURMOUNT trials demonstrated up to 22.5% Body-weight change over 72 weeks, approaching bariatric surgery outcomes.
3. Dual Incretin Mechanism — GIP complements GLP-1 by enhancing adipose insulin sensitivity and fat mobilization.
4. Cardiovascular — Beneficial effects on blood pressure, lipids, and inflammatory markers.
5. Hepatic Benefits — Significant liver fat reduction and improved hepatic inflammation markers.
6. Pharmacokinetics — Once-weekly dosing via C20 fatty diacid albumin binding. References available upon request. The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
No COA report currently listed for this product/batch.
View CoA archive / request available information🇪🇺 EU & UK shipping • Free over €300 • estimated at checkout
Frequently asked questions
- Batch-level CoA information is available where applicable and focuses on purity testing. We do not claim identity testing unless that test exists for the specific batch.
- Store the lyophilised vial at -20°C, protected from light. Once reconstituted for in-vitro work, follow your laboratory's standard handling and stability protocols. Most reconstituted peptides remain stable at 2-8°C for short-term use.
- No. All Peptra Labs peptides are supplied strictly for laboratory and educational research use only. They are not approved for human or veterinary administration, are not evaluated by the FDA or EMA, and must not be used as drugs, supplements, or cosmetic products.
- We ship across the EU and the United Kingdom. Most orders arrive within 2-5 business days. Free shipping on orders over €300.
- Each shipment contains the sealed, clearly labelled vial only. Batch-level CoA information is available in the Lab Reports section where applicable. Research-use warnings are shown on the vial label and site policy pages.
- Yes. Recent lab reports are available in our Lab Reports section. If you'd like the COA for a specific lot before purchasing, contact us at info@peptralabs.com.
